71 results
Page 2 of 4
424B5
4ic57ukooo1bn1tna
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K/A
EX-99.1
tizoro 54fpwdurdf
23 Nov 20
Consolidated Financial Statements
12:00am
424B7
8xah z4rtl
5 Nov 20
Prospectus with selling stockholder info
5:27pm
8-K
EX-10.3
1shl jnlzydkvx8a
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
46h sfquflye
28 Aug 20
Prospectus supplement
4:31pm
425
7szxv9hpcoi
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
rnlhdxa486vg6yw2
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-1.1
tcbneb40 lcuscudr
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
9bpamcv417kqf7 sfir
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
tmj6q96tm4o2gca grf
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K/A
EX-99.1
uawrfvgxwxt2u5dkx2
28 Aug 19
Statement of Operations
4:05pm
8-K/A
EX-99.2
bb6t4inr05d4rumiz
28 Aug 19
Statement of Operations
4:05pm